Information

01.12.2019

Modification of various documents relating to authorisation

ZL000_00_024e_WL / ZL101_00_007e_WL / ZL300_00_001e_WL

22.11.2019

Potential nitrosamine contamination: request to perform a risk evaluation

Marketing authorisation holders of human medicinal products asked to conduct their own evaluation of the potential risk of contamination with nitrosamines.

18.10.2019

Adaptation of the Forms Renewal of authorisation HMV4

ZL201_00_008e_FO / ZL201_00_010e_FO

30.09.2019

Fixed texts for medicinal products which are being reallocated from dispensing category C to B as of 2019

Adaptation of fixed texts for medicinal products that may continue to be dispensed by pharmacies without a medical prescription after expert advice.

09.09.2019

Adaptation of the Form Renewal of authorisation HMV4

ZL201_00_007e_FO / ZL201_00_008e_FO / ZL201_00_010e_FO

20.08.2019

SwissPAR HMV4 guidance document modified

ZL000_00_030e_WL